The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes ; volume:22 ; number:1 ; day:9 ; month:3 ; year:2023 ; pages:1-7 ; date:12.2023
Cardiovascular diabetology ; 22, Heft 1 (9.3.2023), 1-7, 12.2023
- Creator
-
Retnakaran, Ravi
Pu, Jiajie
Ye, Chang
Emery, Alexandra
Kramer, Caroline K.
Zinman, Bernard
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-023-01781-z
- URN
-
urn:nbn:de:101:1-2502211418589.234660242143
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Retnakaran, Ravi
- Pu, Jiajie
- Ye, Chang
- Emery, Alexandra
- Kramer, Caroline K.
- Zinman, Bernard
- SpringerLink (Online service)
Other Objects (12)
Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
Adding to the spectrum of insulin sensitive populations for mixed meal tolerance test glucose reliability assessment
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes
An SMS-Guided Basal Insulin Titration in People with Type 2 Diabetes New on Insulin
Switching the basal insulin to insulin glargine 300 u/ml in people with type 2 diabetes under basal insulin supported oral therapy – observational trial on effectiveness and safety
Hemodynamic Response to Glucose-Insulin Infusion and Meals during Hemodialysis
Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
Is vascular insulin resistance an early step in diet-induced whole-body insulin resistance?
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
Adding to the spectrum of insulin sensitive populations for mixed meal tolerance test glucose reliability assessment
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes
An SMS-Guided Basal Insulin Titration in People with Type 2 Diabetes New on Insulin
Switching the basal insulin to insulin glargine 300 u/ml in people with type 2 diabetes under basal insulin supported oral therapy – observational trial on effectiveness and safety
Hemodynamic Response to Glucose-Insulin Infusion and Meals during Hemodialysis
Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
Is vascular insulin resistance an early step in diet-induced whole-body insulin resistance?
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
Adding to the spectrum of insulin sensitive populations for mixed meal tolerance test glucose reliability assessment
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes
An SMS-Guided Basal Insulin Titration in People with Type 2 Diabetes New on Insulin
Switching the basal insulin to insulin glargine 300 u/ml in people with type 2 diabetes under basal insulin supported oral therapy – observational trial on effectiveness and safety
Hemodynamic Response to Glucose-Insulin Infusion and Meals during Hemodialysis
Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
Is vascular insulin resistance an early step in diet-induced whole-body insulin resistance?